These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 27068170)
21. Single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Otgonsuren M; Estep MJ; Hossain N; Younossi E; Frost S; Henry L; Hunt S; Fang Y; Goodman Z; Younossi ZM J Gastroenterol Hepatol; 2014 Dec; 29(12):2006-13. PubMed ID: 25039333 [TBL] [Abstract][Full Text] [Related]
22. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Yki-Järvinen H Lancet Diabetes Endocrinol; 2014 Nov; 2(11):901-10. PubMed ID: 24731669 [TBL] [Abstract][Full Text] [Related]
23. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease. Lebensztejn DM; Białokoz-Kalinowska I; Kłusek-Oksiuta M; Tarasów E; Wojtkowska M; Kaczmarski M Adv Med Sci; 2014 Mar; 59(1):81-4. PubMed ID: 24797980 [TBL] [Abstract][Full Text] [Related]
24. Epidemiology and natural history of non-alcoholic steatohepatitis. Argo CK; Caldwell SH Clin Liver Dis; 2009 Nov; 13(4):511-31. PubMed ID: 19818302 [TBL] [Abstract][Full Text] [Related]
25. Non-alcoholic fatty liver disease: the new epidemic and the need for novel nutritional approaches. Selmi C; Bowlus CL; Keen CL; Gershwin ME J Med Food; 2007 Dec; 10(4):563-5. PubMed ID: 18158823 [TBL] [Abstract][Full Text] [Related]
26. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Preiss D; Sattar N Clin Sci (Lond); 2008 Sep; 115(5):141-50. PubMed ID: 18662168 [TBL] [Abstract][Full Text] [Related]
27. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD). Verma S; Jensen D; Hart J; Mohanty SR Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360 [TBL] [Abstract][Full Text] [Related]
28. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children. El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627 [TBL] [Abstract][Full Text] [Related]
29. Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists. Bergqvist CJ; Skoien R; Horsfall L; Clouston AD; Jonsson JR; Powell EE Intern Med J; 2013 Mar; 43(3):247-53. PubMed ID: 22646061 [TBL] [Abstract][Full Text] [Related]
39. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). Ali R; Cusi K Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360 [TBL] [Abstract][Full Text] [Related]
40. Epidemiology of non-alcoholic fatty liver disease. Bellentani S; Scaglioni F; Marino M; Bedogni G Dig Dis; 2010; 28(1):155-61. PubMed ID: 20460905 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]